Abbott | ABT - Zahlungsmittel Und Äquivalente

Aktienkurs
105.56
Täglich Wechseln
-1.63 -1.52%
Monatlich
-8.44%
Jährlich
-16.45%
Q1 Prognose
104.77




Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 8.52B 1.01B 2025-12
Agilent USD 1.76B 31M 2025-12
AtriCure USD 167.43M 19.56M 2025-12
Baxter International USD 1.97B 240M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Cooper Companies USD 110.6M 14.3M 2025-09
Danaher USD 4.62B 3.09B 2025-12
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.69B 587.2M 2025-09
Globus Medical USD 526.16M 154.39M 2025-12
Hologic USD 2.17B 208.5M 2025-12
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 9.03B 601.6M 2025-12
J&J USD 19.71B 1.48B 2025-12
Masimo USD 312.3M 162.7M 2025-09
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 446.4M 53.95M 2025-12
Pfizer USD 1.34B 295M 2025-09
Solventum Corp USD 878M 764M 2025-12
Stryker USD 4.01B 755M 2025-12
Tandem Diabetes Care USD 90.63M 1.31M 2025-12
Teleflex USD 354M 100.3M 2025-09
Terumo JPY 217.16B 12.86B 2025-09
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12